PVLA ▼ -0.2% - Palvella Therapeutics, Inc. $PVLA - Palvella Therapeutics to Present Phase 3 SELVA and Phase 2 TOIVA Results, Along With New Pediatric Analyses, at 2026 PeDRA Annual Conference 15-OCT-2026 07:30 AM ET